AFT Pharmaceuticals affirms it is on track to break even within two years

AFT Pharmaceuticals affirms it is on track to break even within two years
Pattrick Smellie
By Pattrick Smellie Aug. 5 (BusinessDesk) - Drug developer AFT Pharmaceuticals still expects to break even in the 2018 or 2019 financial year, although it cannot be sure exactly when, founder and managing director Harley Atkinson told shareholders at the company's first annual meeting since dual-listing on the NZX and ASX last December. "FY18 still looks close," said  Atkinson. "We might make a small loss or we might break even next year." The company reported an $8.9 million loss, in line with its prospectus, for the year to March 31,...